CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it received an Import Medical Device Market Approval from... read more
CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it received an Import Medical Device Market Approval from... read more
Eloxx Pharmaceuticals, Inc. (Nasdaq:ELOX) on 4/25/18 announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price to the public of $9.75 per share.... read more
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, reported on 4/25/18 new positive magnetic resonance efficacy results showing slowed disease progression... read more
STEMCELL Technologies announced on 4/25/18 a $45 million joint funding agreement between the Governments of Canada and British Columbia to help the company build a state-of-the-art advanced... read more
Vaxart is a clinical stage biopharmaceutical company that seems to hold a great deal of promise. They are developing several oral tablet vaccines with the most promising being a vaccine for... read more